Since the ACH2.0 defines AD as a disease driven by the production of iAβ in the AβPP-independent pathway, it can be assumed that this attribute is possibly unique (or at least relatively unique) to humans and is inoperative (or operative rarely) in non-human mammalian species. This evidence concerns the gene APP and Alzheimer disease.